Mirae Asset Global Investments Co., Ltd. Neogenomics Inc Transaction History

Mirae Asset Global Investments Co., Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$7.86 - $12.91 $247,346 - $406,264	31,469 Added 98.1%	63,547 $547,000
Q2 2022 Jul 26, 2022	BUY	$7.06 - $13.97 $226,470 - $448,129	32,078 New	32,078 $261,000
Q2 2021 Aug 11, 2021	SELL	$36.62 - $51.69 $26.2 Million - $37 Million	-716,547 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$41.56 - $59.88 $8.64 Million - $12.5 Million	207,938 Added 40.88%	716,547 $34.6 Million
Q4 2020 Feb 10, 2021	BUY	$36.08 - $56.47 $7.24 Million - $11.3 Million	200,749 Added 65.21%	508,609 $27.4 Million
Q3 2020 Nov 12, 2020	BUY	$33.26 - $40.48 $10.2 Million - $12.5 Million	307,860 New	307,860 $11.4 Million

293

125M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.8B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.